ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 65 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $53,000 | +10.4% | 10,000 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $48,000 | -95.5% | 10,000 | -95.9% | 0.01% | -95.7% |
Q4 2020 | $1,063,000 | -27.5% | 245,399 | -31.0% | 0.16% | -37.8% |
Q3 2020 | $1,466,000 | +60.9% | 355,845 | 0.0% | 0.26% | +37.2% |
Q2 2020 | $911,000 | -21.5% | 355,845 | -11.4% | 0.19% | -40.5% |
Q1 2020 | $1,161,000 | -23.2% | 401,845 | +0.8% | 0.32% | +4.9% |
Q4 2019 | $1,511,000 | -48.6% | 398,609 | -30.7% | 0.31% | -58.6% |
Q3 2019 | $2,941,000 | -13.9% | 574,886 | +4.4% | 0.74% | -1.2% |
Q2 2019 | $3,415,000 | -10.5% | 550,836 | +2.6% | 0.75% | -10.4% |
Q1 2019 | $3,817,000 | +89.2% | 536,836 | +127.4% | 0.84% | +49.9% |
Q4 2018 | $2,017,000 | -73.4% | 236,124 | -37.8% | 0.56% | -61.9% |
Q3 2018 | $7,596,000 | -18.3% | 379,424 | +5.5% | 1.46% | -22.2% |
Q2 2018 | $9,294,000 | +76.5% | 359,796 | +63.3% | 1.88% | +78.5% |
Q1 2018 | $5,265,000 | +54.9% | 220,296 | +119.6% | 1.05% | +52.0% |
Q4 2017 | $3,399,000 | – | 100,300 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |